Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D0D1SG
|
||||
Former ID |
DIB011425
|
||||
Drug Name |
Prednisolone
|
||||
Synonyms |
Nanocort; Prednisolone (injectable liposome formulation, rheumatoid arthritis); Prednisolone (injectable liposome formulation, rheumatoid arthritis), Enceladus; Prednisolone (injectable liposome formulation, rheumatoid arthritis), Galapagos
|
||||
Drug Type |
Small molecular drug
|
||||
Therapeutic Class |
Anticancer Agents
|
||||
Company |
Schering Corp Sub Schering Plough Corp
|
||||
Structure |
Download2D MOL |
||||
Formula |
C21H28O5
|
||||
InChI |
InChI=1S/C21H28O5/c1-19-7-5-13(23)9-12(19)3-4-14-15-6-8-21(26,17(25)11-22)20(15,2)10-16(24)18(14)19/h5,7,9,14-16,18,22,24,26H,3-4,6,8,10-11H2,1-2H3/t14-,15-,16-,18+,19-,20-,21-/m0/s1
|
||||
InChIKey |
OIGNJSKKLXVSLS-VWUMJDOOSA-N
|
||||
PubChem Compound ID | |||||
PubChem Substance ID |
9573, 74674, 75254, 7847538, 7980377, 8153532, 10321429, 11466302, 11467422, 11486103, 12012573, 12146616, 14876794, 14876795, 24870351, 24898079, 24898725, 26697414, 29224791, 46504847, 46519223, 47500929, 47647896, 47945232, 48244811, 48414366, 48416460, 49698415, 49857644, 50085972, 50124371, 50643467, 53790825, 56311149, 56312886, 56313992, 56463372, 57288815, 57650843, 81093218, 85300842, 85788424, 87574796, 92125114, 92309181, 92710510, 93576750, 103189031, 103913923, 104169971
|
||||
Target and Pathway | |||||
Target(s) | Glucocorticoid receptor | Target Info | Modulator | [525912] | |
KEGG Pathway | Neuroactive ligand-receptor interaction | ||||
NetPath Pathway | IL2 Signaling Pathway | ||||
TCR Signaling Pathway | |||||
References | |||||
Ref 525302 | ClinicalTrials.gov (NCT02534896) To Evaluate The Efficacy And Safety Of Intravenous Pegylated Liposomal Prednisolone Sodium Phosphate (Nanocort) Compared With Intramuscular Injection Of Methylprednisolone Acetate In Subjects With Active Rheumatoid Arthritis. | ||||
Ref 539891 | (http://www.guidetopharmacology.org/) Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 2866). | ||||
Ref 551871 | Drugs@FDA. U.S. Food and Drug Administration. U.S. Department of Health & Human Services. 2015 |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.